Important Clarification: Melanoptysis vs. Melanopsia
I need to address a critical terminology issue first. "Melanoptysis" (coughing up melanoma tumor tissue) is an extremely rare presentation of metastatic melanoma to the lungs, while "melanopsia" refers to a visual disturbance (seeing dark spots). These are completely different clinical entities.
If Your Patient Has Melanoptysis (Coughing Up Tumor Tissue):
Yes, absolutely obtain a chest CT scan immediately—this represents advanced metastatic melanoma requiring urgent evaluation. 1
Melanoptysis indicates:
- Large endobronchial or pulmonary metastatic disease
- Central airway involvement
- Need for immediate staging and palliative intervention
- This is a stage IV presentation requiring chest/abdominal/pelvic CT and brain MRI 2
If Your Patient Has Melanopsia (Visual Disturbance):
No, do not obtain a chest CT for melanopsia alone—obtain brain imaging (MRI preferred) if you suspect melanoma metastases to the CNS. 2
For melanopsia with known melanoma:
- Brain MRI or CT with contrast is indicated if there are any CNS symptoms 2
- Chest CT is only indicated based on melanoma stage and presence of other symptoms, not for visual symptoms
General Melanoma Staging Imaging Guidelines:
Routine chest CT is NOT recommended for asymptomatic patients with stage I-II melanoma, regardless of symptoms unrelated to metastatic disease. 2, 3
Stage-Based Approach:
Stage I-IIA:
Stage IIB-IIC:
Stage III:
- Imaging at physician discretion 2
- Chest/abdominal CT or PET/CT reasonable for clinically positive nodes 2
- Yield of detecting occult metastases: 0.5-3.7% for positive sentinel nodes, 4-16% for clinically positive nodes 2
Stage IV:
- Chest/abdominal/pelvic CT with or without PET/CT indicated 2
- Brain MRI or CT with contrast for any CNS symptoms 2
Key Evidence Points:
The yield of routine CT in asymptomatic early-stage melanoma is extremely low (0.7% at initial presentation) 4, 5, with false-positive findings (19-22%) far exceeding true positives 6, 5. False-positive findings lead to unnecessary biopsies, patient anxiety, and increased morbidity without proven survival benefit. 2, 3
Clinical Pitfalls:
- Do not order "routine" staging CT for stage I-II disease—it causes more harm than good
- Most recurrences in high-risk patients are detected clinically (41.5%) rather than by imaging (56.7%), with no proven survival advantage to intensive imaging 3
- If imaging is obtained and shows suspicious findings, always obtain histologic confirmation given the high false-positive rate 6
Bottom line: Clarify whether your patient has melanoptysis (tumor expectoration) or melanopsia (visual disturbance), as this fundamentally changes the answer. For melanoptysis, urgent chest CT is mandatory. For melanopsia or other non-metastatic symptoms, follow stage-based imaging guidelines and do not obtain chest CT unless clinically indicated by melanoma stage or specific respiratory symptoms.